Back

Candesartan Cilexetil/HCTZ  Tablets

16/12.5 mg

cardiovascular

details

Candesartan/HCTZ is a combination product of Candesartan and Hydrochlorothiazide, indicated for the treatment of hypertension and congestive heart failure. This combination product is selected for patients whose blood pressure is not adequately controlled on monotherapy.
Unipharm’s generic Candesartan Cilexetil/HCTZ Tablets have been manufactured and marketed in Israel since 2014.

  • ATC4: C09CA
  • Strengths: 16/12.5 mg
  • Dosage form: Tablets
  • Out-licensing is offered for all international markets*
  • Zone IVb stability data is available
* Product availability is subject to patent restrictions in countries where applicable patents are in effect

related products

Amlodipine Besilate
Tablets

5 & 10 mg
Amlodipine Besilate/Valsartan
Tablets

5 /80, 5/160 & 10/160 mg
Candesartan Cilexetil
Tablets

8 & 16 mg
Cilazapril
Tablets

1, 2.5 & 5 mg
Cilazapril/HCTZ
Tablets

5/12.5 mg
Lercanidipine HCl
Tablets

10 & 20 mg
Losartan Potassium
Tablets

12.5, 50 & 100 mg
Losartan Potassium/HCTZ
Tablets

50/12.5 mg
Valsartan
Tablets

40, 80 & 160 mg
Valsartan/HCTZ
Tablets

80/12.5, 160 /12.5 &160 /25 mg